本帖最后由 成长的烦恼 于 2012-6-27 20:19 编辑
3 [5 `! R4 K' V2 f
4 p% p% l, r' Z" f+ pclinicaltrials上的三期临床链接4 N4 _$ P# L: E8 n
+ ?/ A$ l3 a: U4 E d" U E6 Hhttp://clinicaltrials.gov/ct2/sh ... mp;show_locs=Y#locn2 N/ g3 \8 W2 K1 {: @
, ?5 g$ G' s2 g中国参加临床实验的城市* a. v% E# s, [
1 B- j& X2 W2 o# U) {China, Guangdong
/ r/ j5 L4 W$ r% T( u7 ^% u7 ] + I/ o+ m( V: H+ _ S$ T3 [
Guangzhou, Guangdong, China, 510515
& I" P4 ~: c, T8 u1 D; _! L2 e. @ F 8 I) W! \) ]; r5 N
Guangzhou, Guangdong, China, 510060 # i1 ^8 J: {0 ^) R7 v
China, Jiangsu 6 x1 n) v9 [' r# b9 E! V5 G9 |
) o& E2 ?' _+ g" c% i1 m9 K
Nanjing, Jiangsu, China, 210009
/ S; S8 \" E+ h0 e1 v z
% O) x* ~& I, @. P( T9 C1 G" UNanjing, Jiangsu, China, 210002
2 i9 N' T3 P: @5 }& j6 T! wChina, Shandong ( p3 u, [! f, d5 J
' `) b. \, u1 z1 e6 ]/ }6 {! @7 RQingdao, Shandong, China, 266003
& l% n: a4 X, XChina 0 {/ d* m; n$ W6 j7 i4 N6 i4 y: ^0 E
/ z+ @6 \4 A2 ?1 J) |6 n- [0 q
Beijing, China, 100021 5 s6 y4 I2 x6 b- y" [# j+ P$ M" r8 b
$ K7 b6 E% [. _. s
Beijing, China, 100071
" \' I; Z g h! P7 r + d' R" f0 q5 S/ k5 R9 Y
Changchun, China, 130021 " V9 q( Y6 \. d' Y- [5 K1 ?
" d& B+ X9 b5 a& T6 NChongqing, China, 400042 5 g, \# J( @# H6 M) u3 s
# R) \! B. }- b3 A" E
Chongqing, China, 400038 ( g6 _; p* p: w. S; S$ m5 k
% h( I" [2 ~( c1 B2 m' j# k/ K
Fuzhou, China, 350014 3 w( E F6 k: S8 D( p
( |1 @4 D6 A- m
Fuzhou, China, 350025
' _0 |: f5 t# v( h$ C' X. o 9 L) t: E: P% A
Ha'erbin, China, 150040 : a" N% K& r6 }) H
. o3 |! ~& ?( {* J( T5 E. ]Hanghzou, China, 310009
" K/ ^! {% h8 O1 M# d
9 M! M. W, j& TShanghai, China, 200001
: l) Z# y6 h3 k1 f4 k. s
% p% L4 | w' Q' {3 LShanghai, China, 200030
6 F0 v% h; V: D- W, h! ~ l& c9 ^' T6 O2 Y
Tianjin, China , ?% o+ \+ m. F& ^2 e
7 p$ k" C2 \( M2 r7 \. w9 G
该实验已停止招募,重新开的临床请见临床专用贴。 |